Fifth Addendum to Consulting Agreement Dated February 1, 2000Consulting Agreement • March 31st, 2008 • Avalon Pharmaceuticals Inc • Pharmaceutical preparations
This Fifth Addendum is made by and between Avalon Pharmaceuticals, Inc. (formerly Therapeutic Genomics, Inc.) a Delaware corporation, located at 20358 Seneca Meadows Parkway, Germantown, MD 20876 (“AVALON”), and Bradley G. Lorimier, an individual with an address at 7807 Fox Gate Court, Bethesda, MD 20817 (“CONSULTANT”).
THIRD MODIFICATION AGREEMENTThird Modification Agreement • March 31st, 2008 • Avalon Pharmaceuticals Inc • Pharmaceutical preparations • Maryland
THIS THIRD MODIFICATION AGREEMENT (“AGREEMENT”) is made to be effective as of the 14 day of December, 2006, by and between MANUFACTURERS AND TRADERS TRUST COMPANY (“BANK”); MARYLAND INDUSTRIAL DEVELOPMENT FINANCING AUTHORITY (“ISSUER”); and AVALON PHARMACEUTICALS, INC. (“BORROWER”).
Amendment No. 6 to CONSULTING AGREEMENT By and Between Avalon Pharmaceuticals, Inc. and Bradley G. LorimierConsulting Agreement • March 31st, 2008 • Avalon Pharmaceuticals Inc • Pharmaceutical preparations
The parties hereby agree, effective August 1, 2007 (“Effective Date”), to amend the Consulting Agreement by and between Avalon Pharmaceuticals, Inc. (“Company” or “the Company”) and Bradley G. Lorimier (“Consultant” or “the Consultant”) as set forth herein.
